申请人:Hoffmann-La Roche Inc.
公开号:US11390604B2
公开(公告)日:2022-07-19
The disclosure provides novel imidazole pyrazole derivatives having the general formula (I), and pharmaceutically acceptable salts thereof, wherein X1, RA and R3 to R7 are as described herein:
Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.
本公开提供了具有通式 (I) 的新型咪唑吡唑衍生物及其药学上可接受的盐类,其中 X1、RA 和 R3 至 R7 如本文所述:
还提供了包括这些化合物的药物组合物、制造这些化合物的工艺以及将这些化合物用作药物的方法,特别是将这些化合物用作抗生素以治疗或预防细菌感染及其引起的疾病的方法。